GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 125 filers reported holding GOSSAMER BIO INC in Q4 2020. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $499 | +38.6% | 600 | +100.0% | 0.00% | – |
| Q2 2023 | $360 | -66.6% | 300 | -64.9% | 0.00% | – |
| Q1 2023 | $1,077 | -46.2% | 855 | +28.4% | 0.00% | – |
| Q4 2022 | $2,000 | -60.0% | 666 | +93.6% | 0.00% | – |
| Q3 2022 | $5,000 | +66.7% | 344 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -88.5% | 344 | -88.5% | 0.00% | – |
| Q1 2022 | $26,000 | -42.2% | 2,994 | -24.6% | 0.00% | – |
| Q4 2021 | $45,000 | -13.5% | 3,972 | -4.7% | 0.00% | – |
| Q3 2021 | $52,000 | +79.3% | 4,167 | +16.8% | 0.00% | – |
| Q2 2021 | $29,000 | +163.6% | 3,567 | +193.1% | 0.00% | – |
| Q1 2021 | $11,000 | -8.3% | 1,217 | -1.3% | 0.00% | – |
| Q4 2020 | $12,000 | -29.4% | 1,233 | -14.0% | 0.00% | – |
| Q3 2020 | $17,000 | +41.7% | 1,433 | +53.6% | 0.00% | – |
| Q2 2020 | $12,000 | +33.3% | 933 | +1.6% | 0.00% | – |
| Q1 2020 | $9,000 | – | 918 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,164,835 | $27,471,000 | 5.62% |
| Kynam Capital Management, LP | 1,832,704 | $15,908,000 | 5.16% |
| Octagon Capital Advisors LP | 2,563,138 | $22,248,000 | 4.81% |
| Ally Bridge Group (NY) LLC | 450,000 | $3,906,000 | 2.90% |
| HHLR ADVISORS, LTD. | 7,420,974 | $64,414,000 | 1.34% |
| Palo Alto Investors LP | 1,756,757 | $15,249,000 | 1.18% |
| Boxer Capital, LLC | 2,462,358 | $21,373,000 | 1.10% |
| Ikarian Capital, LLC | 775,315 | $6,730,000 | 0.88% |
| Artal Group S.A. | 2,358,968 | $20,476,000 | 0.86% |
| Birchview Capital, LP | 129,088 | $1,120,000 | 0.81% |